Finance

Beta
Lists
NMRA:NASDAQ
Neumora Therapeutics Inc
$1.82
-1.62%
(-0.030) 1D
$1.85
+1.65% (+0.030)
After hours
Closed: Jun 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NMRA...
Open
$1.85
High
$1.89
Low
$1.78
Mkt. cap
337.22M
Avg. vol.
1.42M
Volume
0.00
52-wk high
$3.65
52-wk low
$0.69
EPS
-$1.33
Shares outstanding
185.28M
No. of employees
92
Open
$1.85
High
$1.89
Low
$1.78
Mkt. cap
337.22M
Avg. vol.
1.42M
Volume
0.00
52-wk high
$3.65
52-wk low
$0.69
EPS
-$1.33
Shares outstanding
185.28M
No. of employees
92
News stories
From sources across the web
About Neumora Therapeutics Inc
CEO-
Employees92
Founded2019
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteneumoratx.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.30 / -$0.31
+3.23%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
38.72M
40.52M
44.67M
38.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.32M
12.18M
13.81M
14.27M
Operating expense
54.04M
52.70M
58.48M
52.86M
Total operating expenses
54.04M
52.70M
58.48M
52.86M
Operating income
-54.04M
-52.70M
-58.48M
-52.86M
Other non operating income
-480.00K
7.00K
-269.00K
59.00K
EBT including unusual items
-52.71M
-56.76M
-59.45M
-53.43M
EBT excluding unusual items
-52.71M
-51.76M
-59.45M
-53.43M
Income tax expense
25.00K
-
-
30.00K
Effective tax rate
-0.05%
-
-
-0.06%
Other operating expenses
-
-
-
-
Net income
-52.73M
-56.76M
-59.45M
-53.46M
Net profit margin
-
-
-
-
Earnings per share
-0.33
-0.35
-0.35
-0.30
Interest and investment income
1.81M
1.68M
1.34M
1.23M
Interest expense
-
-747.00K
-2.04M
-1.85M
Net interest expenses
1.81M
938.00K
-701.00K
-623.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-54.02M
-52.68M
-58.47M
-52.81M
Gain or loss from assets sale
440.00K
-62.00K
264.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer